Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
octreotide
octreotide
Brand names: Octreotide Acetate, SandoSTATIN LAR Depot
| Form | Strength |
|---|---|
| POWDER FOR INJECTION, INTRAMUSCULAR | 10 mg; 20 mg; 30 mg |
| SOLUTION, INJECTABLE | 50 mcg/mL; 100 mcg/mL; 200 mcg/mL; 500 mcg/mL; 1000 mcg/mL |
Last updated: Jan. 9, 2024
Solution for injection vials are labeled for SC administration but may be given IV (per manufacturer). Refer to medication order for specified route of administration.
The long acting (LAR) intramuscular injection is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.